Biopharmaceutical company Scholar Rock Holding Corp (SRRK) recently announced that regarding the resubmission of its Biologics License Application (BLA), the company expects the U.S. Food and Drug Administration (FDA) to accept the filing within 30 days and initiate the formal review process.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Disney (DIS.US) reportedly plans to lay off thousands of employees, with some managers being asked to save 20% of annual costs.
According to informed sources, Disney (DIS.US) is planning to lay off thousands of employees. The entertainment giant has asked some managers to set their annual cost-saving targets at 20%.
South Korea launches record-breaking budget for AI: 4.7 trillion won to build a "global highest-performance" sovereign model
South Korean President Lee Jae-myung has announced the largest fiscal budget in history—820.9 trillion won, representing a 12.8% surge from the previous year. The investment in AI and semiconductor initiatives will double to 1 trillion won, with an additional 4.7 trillion won allocated specifically for developing a "world’s highest-performance" sovereign AI model. Robust exports provide real support for these ambitions: South Korea’s exports in October alone soared by 93.7% to a record $115.3 billions, with annual exports on the brink of surpassing the $1 trillions milestone.
Crypto prices
More
